Tapiwanashe Kujinga

Should disability-inclusive health be a priority in low-income countries? A case-study from Zimbabwe

H. Kuper, S. Rusakaniko, Tracey Smythe, 2022, Global health action.

Tackling antimicrobial resistance across sub-Saharan Africa: current challenges and implications for the future

Z. Saleem, J. Mwita, A. Guantai, 2022, Expert opinion on drug safety.

A path toward disability-inclusive health in Zimbabwe Part 1: A qualitative study on access to healthcare

H. Kuper, S. Rusakaniko, Tracey Smythe, 2022, African journal of disability.

A path toward disability-inclusive health in Zimbabwe Part 2: A qualitative study on the national response to COVID-19

H. Kuper, S. Rusakaniko, Tracey Smythe, 2022, African journal of disability.

Treatment of advanced AIDS-associated Kaposi sarcoma in resource-limited settings: a three-arm, open-label, randomised, non-inferiority trial

W. Wachsman, C. Rinaldo, C. Moser, 2020, The Lancet.

Developing and implementing national health identifiers in resource limited countries: why, what, who, when and how?

J. Garcia-Calleja, P. Ghys, E. Beck, 2018, Global health action.

Antimicrobial resistance control efforts in Africa: a survey of the role of Civil Society Organisations

V. J. Del Rio Vilas, C. Schultsz, J. Varma, 2021, Global health action.

Patent challenges in the procurement and supply of generic new essential medicines and lessons from HIV in the southern African development community (SADC) region.

P. Boulet, Tapiwanashe Kujinga, E. '. ‘t Hoen, 2018, Journal of pharmaceutical policy and practice.

Patent challenges in the procurement and supply of generic new essential medicines and lessons from HIV in the southern African development community (SADC) region.

P. Boulet, Tapiwanashe Kujinga, E. '. ‘t Hoen, 2018, Journal of Pharmaceutical Policy and Practice.